A prospective study to evaluate the usefulness of thrombomodulin-alpha in patients with severe acute pancreatitis.
Phase 2
Recruiting
- Conditions
- Severe acute pancreatitis
- Registration Number
- JPRN-UMIN000029126
- Lead Sponsor
- rTM for SAP study group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with allergy for thrombomodulin alpha. Pregnant patients or patients who were suspected pregnancy. Patients whose informed consent could not be obtained. In case that doctors judged inappropriate for the entry.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival at the 28 day after onset of pancreatitis
- Secondary Outcome Measures
Name Time Method Prognostic score, occurrence of local complications, and performance status of the patients at the 28 day after onset of the pancreatitis